Parasutterella sp.

Information

Microbe Identification

Parasutterella sp.

Microbe id: PMDBM2021658
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Parasutterella sp. [2049037]
Taxonomy Genus: Parasutterella [577310]
Taxonomy Family: Sutterellaceae [995019]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Parasutterella sp.

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Parasutterella sp.


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Parasutterella sp. distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Parasutterella sp. in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Parasutterella sp.

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJEB65297🔗-3.22682813048925mNGS
Kidney Failure, Chronic PRJNA449784🔗-3.2065647534166mNGS
Hypertension PRJNA509999🔗3.46020920187818mNGS
Dwarfism PRJNA808649🔗-3.65019430712422mNGS
Dwarfism PRJNA819198🔗-3.3265718842168916S
Colorectal Neoplasms PRJEB53891🔗-3.82927822847259mNGS
Colorectal Neoplasms PRJNA1138893🔗-3.76393658642492mNGS
Colorectal Neoplasms PRJNA1167935🔗-3.27667514072mNGS
Colorectal Neoplasms PRJEB46665🔗-2.4586915477576216S
Colorectal Neoplasms PRJNA731589🔗3.57481659540093mNGS
Tuberculosis, Gastrointestinal PRJNA743795🔗-3.6246403446645416S
Diabetes Mellitus, Type 1 PRJNA766410🔗-4.2018575907760616S
Parkinson Disease PRJNA762484🔗-3.4560416593679mNGS
Colitis, Ulcerative PRJNA429990🔗-3.01040849836437mNGS
Colitis, Ulcerative PRJNA820056🔗2.1113024999958816S
Colitis, Ulcerative PRJNA398089🔗3.61516417310401mNGS
Carcinoma, Hepatocellular PRJNA932948🔗-3.06397059913777mNGS
Helicobacter Infections PRJDB10599🔗-3.6519864768211616S
Hepatolenticular Degeneration PRJNA1038771🔗-3.2289202424704516S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-3.6660987560262616S
Schizophrenia PRJNA1135717🔗-3.97963384572332mNGS
Asthma PRJNA950484🔗4.099412802738716S
Crohn Disease PRJNA938107🔗-3.5244740235640216S
Crohn Disease PRJNA793776🔗-3.12939969548825mNGS
Crohn Disease PRJNA820056🔗2.0743491667897716S
Polycystic Ovary Syndrome PRJEB38647🔗3.8755495573854516S
Cholestasis PRJNA478781🔗-3.316120463742716S
Multiple System Atrophy PRJNA386851🔗-2.535421381495116S
Dermatitis, Atopic PRJEB45443🔗-2.98928964674309mNGS
Arthritis, Rheumatoid PRJNA786110🔗-3.7621025512358416S
Arthritis, Rheumatoid PRJNA356102🔗-3.22275428037341mNGS
Arthritis, Rheumatoid PRJNA896336🔗3.66138476856478mNGS
Cholangiocarcinoma PRJNA932948🔗-2.94065752426301mNGS
Anorexia Nervosa PRJEB38930🔗-3.5544105803056316S
Hepatitis C PRJNA1070593🔗-3.7575881217939116S
Neuroblastoma PRJEB63351🔗-3.08369655107375mNGS
Hematologic Neoplasms PRJNA777832🔗3.2171574161039116S
Irritable Bowel Syndrome PRJNA705217🔗-3.45344498999902mNGS
Irritable Bowel Syndrome PRJNA682378🔗-3.4415495069949116S
Irritable Bowel Syndrome PRJEB37924🔗2.99249786125458mNGS
Gastroesophageal Reflux PRJNA993632🔗3.50446613028214mNGS
Schistosomiasis japonica PRJNA625383🔗-4.3526052986279916S
Diabetes, Gestational PRJNA853814🔗3.53447967552905mNGS
Kidney Calculi PRJNA742740🔗-3.30290347980082mNGS
Cholelithiasis PRJNA999028🔗-3.77015943237156mNGS
Alzheimer Disease PRJEB51982🔗-3.3449611794121616S
Atrial Fibrillation PRJNA728204🔗-3.9953472189327516S
Fatty Liver, Alcoholic PRJNA690835🔗3.5749453812421516S
Glomerulonephritis, IGA PRJNA785415🔗-3.3152443449326216S
Cystic Fibrosis PRJNA314903🔗-3.12855525851023mNGS
Hypercholesterolemia PRJNA842179🔗-2.542364390567516S
HIV Infections PRJDB11949🔗-3.5932320762685616S
Autism Spectrum Disorder PRJNA686821🔗2.96360069196061mNGS
Neuromyelitis Optica PRJNA662563🔗3.845773488238316S
Inflammatory Bowel Diseases PRJNA993675🔗-3.27918224649825mNGS
Hand, Foot and Mouth Disease PRJNA843173🔗3.8300909651918616S
Biliary Atresia PRJNA730640🔗-4.0830400689393mNGS
Renal Insufficiency, Chronic PRJNA949558🔗-3.9363603864394816S
Renal Insufficiency, Chronic PRJNA562327🔗-3.6641169676533616S
Renal Insufficiency, Chronic PRJEB65297🔗-3.48340790645605mNGS
Multiple Sclerosis PRJNA875026🔗-3.4829145474139416S
Breast Neoplasms PRJNA658160🔗3.2831144951326616S
Breast Neoplasms PRJNA383849🔗3.3991991045949316S
COVID-19 PRJNA907010🔗-4.0022968243809916S
COVID-19 PRJNA769052🔗-3.855739720154716S

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Parasutterella sp.



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Parasutterella sp.



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Parasutterella sp.

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Parasutterella sp.


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Parasutterella sp.



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Parasutterella sp.

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Parasutterella sp.

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Parasutterella sp.

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Parasutterella sp.



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Parasutterella sp.


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Parasutterella sp.


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?